🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India · Delayed Price · Currency is INR
2,648.00
+27.00 (1.03%)
At close: Nov 20, 2026

Glenmark Pharmaceuticals Statistics

Total Valuation

BOM:532296 has a market cap or net worth of INR 747.33 billion. The enterprise value is 748.49 billion.

Market Cap747.33B
Enterprise Value 748.49B

Important Dates

The last earnings date was Thursday, November 5, 2026.

Earnings Date Nov 5, 2026
Ex-Dividend Date Aug 31, 2026

Share Statistics

Current Share Class 282.22M
Shares Outstanding n/a
Shares Change (YoY) +0.01%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) 1.24%
Owned by Institutions (%) 29.07%
Float 150.20M

Valuation Ratios

The trailing PE ratio is 51.51 and the forward PE ratio is 30.29.

PE Ratio 51.51
Forward PE 30.29
PS Ratio 4.67
PB Ratio 6.67
P/TBV Ratio 8.64
P/FCF Ratio n/a
P/OCF Ratio 184.01
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 51.57
EV / Sales 4.68
EV / EBITDA 22.49
EV / EBIT 27.67
EV / FCF n/a

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.13.

Current Ratio 1.69
Quick Ratio 0.90
Debt / Equity 0.13
Debt / EBITDA 0.42
Debt / FCF n/a
Interest Coverage 13.40

Financial Efficiency

Return on equity (ROE) is 13.96% and return on invested capital (ROIC) is 21.21%.

Return on Equity (ROE) 13.96%
Return on Assets (ROA) 7.18%
Return on Invested Capital (ROIC) 21.21%
Return on Capital Employed (ROCE) 19.47%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 9.44M
Profits Per Employee 856,446
Employee Count16,946
Asset Turnover 0.79
Inventory Turnover 1.48

Taxes

In the past 12 months, BOM:532296 has paid 4.52 billion in taxes.

Income Tax 4.52B
Effective Tax Rate 23.76%

Stock Price Statistics

The stock price has increased by +43.90% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +43.90%
50-Day Moving Average 2,400.36
200-Day Moving Average 2,266.41
Relative Strength Index (RSI) 66.49
Average Volume (20 Days) 33,691

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:532296 had revenue of INR 159.97 billion and earned 14.51 billion in profits. Earnings per share was 51.41.

Revenue159.97B
Gross Profit 107.86B
Operating Income 27.05B
Pretax Income 19.03B
Net Income 14.51B
EBITDA 32.09B
EBIT 27.05B
Earnings Per Share (EPS) 51.41
Full Income Statement

Balance Sheet

The company has 12.91 billion in cash and 14.07 billion in debt, with a net cash position of -1.17 billion.

Cash & Cash Equivalents 12.91B
Total Debt 14.07B
Net Cash -1.17B
Net Cash Per Share n/a
Equity (Book Value) 112.12B
Book Value Per Share 397.29
Working Capital 52.07B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.06 billion and capital expenditures -12.33 billion, giving a free cash flow of -8.26 billion.

Operating Cash Flow 4.06B
Capital Expenditures -12.33B
Depreciation & Amortization 5.03B
Net Borrowing -2.04B
Free Cash Flow -8.26B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.42%, with operating and profit margins of 16.91% and 9.07%.

Gross Margin 67.42%
Operating Margin 16.91%
Pretax Margin 11.90%
Profit Margin 9.07%
EBITDA Margin 20.06%
EBIT Margin 16.91%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.09%.

Dividend Per Share 2.50
Dividend Yield 0.09%
Dividend Growth (YoY) -50.00%
Years of Dividend Growth 1
Payout Ratio 14.63%
FCF Payout Ratio n/a
Buyback Yield -0.01%
Shareholder Yield 0.09%
Earnings Yield 1.94%
FCF Yield -1.11%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for BOM:532296 is 2,703.09, which is 2.08% higher than the current price. The consensus rating is "Buy".

Price Target 2,703.09
Price Target Difference 2.08%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (3Y) 8.03%
EPS Growth Forecast (3Y) 2.24%

Stock Splits

The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.

Last Split Date Sep 10, 2007
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score 4